GFLT:OTC-GFLT (USD)

COMMON STOCK | Metal Fabrication |

Last Closing

USD 5

Change

0.00 (0.00)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Healthcare Business Resources Inc. manufactures and sells marine containers. The company is based in Nashville, Tennessee.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for Metal Fabrication

Symbol Name Price(Change) Market Cap
TKAMY Thyssenkrupp AG ADR

+0.02 (+0.52%)

USD 2.40B
TYEKF Thyssenkrupp AG O.N.

+0.03 (+0.79%)

USD 2.39B
RYBIF Ryobi Limited

N/A

USD 0.46B
ADFJF ADF Group Inc

-0.05 (-0.63%)

USD 0.25B
LQMT Liquidmetal Technologies Inc

N/A

USD 0.05B
CYMHF Cymat Technologies Ltd

N/A

USD 5.83M
IAALF IBC Advanced Alloys Corp

N/A

USD 5.67M
AMGY American Metal & Technology In..

N/A

USD 0.48M
MUEL Paul Mueller Co

N/A

N/A
AIAGF Aurubis AG

N/A

N/A

ETFs Containing GFLT

N/A

Market Performance

  Market Performance vs. Industry/Classification (Metal Fabrication) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike